Table 2.
The mechanisms of action of single Chinese herbs in the treatment of AD.
| Herb | Mechanisms of actions |
|---|---|
| (i) Increase in cholinergic neuron function, | |
| (ii) Protection against the Aβ protein induced oxidative damages (degrading hydrogen peroxide, preventing lipid from oxidation and trapping reactive oxygen species), | |
| G. biloba [20] | (iii) Prevention of Aβ protein induced fibrillogenesis as well as the formation ADDLs, |
| (iv) Inhibition of cholesterol-induced overproduction of APP, | |
| (v) Anti-apoptosis (opposing mitochondria-initiated apoptosis, downgrading caspase-12, upgrading BCL2), | |
| (vi) Regulation of gene expression | |
|
| |
| (i) Protection against the Aβ protein and hydrogen peroxide induced oxidative damages | |
| (ii) Anti-apoptosis (regulating gene expression: Bcl-2, Bax, P53 and caspase-3), | |
| (iii) Modulating secretary APP and protein kinase C-α, | |
| Huperzine A [21, 22] | (iv) Protection against hypoxia, ischemia and glutamate induced brain injury and cytotoxiicity, |
| (v) Antagonizing effects on NMDA (N-methyl-D-aspartate) receptors, | |
| (vi) Regulation of the expression and secretion of nerve growth factor and its signaling | |
|
| |
| Uncaria rhynchophylla [23] | (i) Inhibition of aggregation of Aβ protein, |
| (ii) Destabilization of preformed Aβ neurofibrills | |
|
| |
| (i) Increase in the uptake of choline in central nervous system, | |
| (ii) Release of acetylcholine from hippocampus, | |
| Ginseng [19] | (iii) Increase in choline acetyltransferase, |
| (iv) Protection against the Aβ protein induced neurotoxic effects, | |
| (v) Repair of Aβ-damaged neuron networks, | |
| (vi) Reducing the level of Aβ | |
|
| |
| Tenuigenin (P. tenuifolta) [24] | (i) Decrease of the secretion of Aβ protein via BACE1 (β-secretase) inhibition |
|
| |
| (i) Alteration of the processing of amyloidal precursor protein, | |
| Berberine (C. rhizoma) [25, 26] | (ii) Decrease of the secretion of Aβ protein, |
| (iii) Acetylcholinesterase inhibitory activity | |
|
| |
| Indirubins [27] | (i) Inhibition of abnormal tau phosphorylation by inhibiting glycogen synthase kinase-3 beta and CDK5/p25 |